Detailed answers about DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED founded?
DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED was officially incorporated on 25 July 2007 and is registered under company number SC328305. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED?
DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED do?
DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED's registered address?
The registered office address of DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED is 7 CASTLETON GROVE, NEWTON MEARNS, GLASGOW, SCOTLAND, G77 5LH. This is the official address filed with Companies House for legal and statutory correspondence.
Is DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED financially stable?
The most recent accounts for DI-EP BIOMEDICAL EDITORIAL SERVICES LIMITED were made up to 30 June 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2026.